Elixinol Wellness Limited (ELLXF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Elixinol Wellness Limited (ELLXF) trades at $0.01. Elixinol Wellness Limited manufactures and distributes hemp-derived nutraceuticals, cosmetics, and food products. Market cap: $1.61M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for ELLXF: ELLXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ELLXF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ELLXF: 1/1 perspectives are bearish.
How is this calculated? →Elixinol Wellness Limited (ELLXF) Healthcare & Pipeline Overview
Elixinol Wellness Limited, operating in the specialty and generic drug manufacturing sector, focuses on hemp-derived products, including nutraceuticals, cosmetics, and food. With a global presence spanning the Americas, Europe, and Australia, the company leverages its Elixinol and Hemp Foods Australia brands to cater to the growing market for hemp-based wellness products.
What Is the Investment Thesis for ELLXF?
Elixinol Wellness Limited presents a speculative investment opportunity within the rapidly evolving hemp-derived products market. The company's negative P/E ratio of -0.41 and a negative profit margin of -35.4% indicate current challenges in achieving profitability. Growth catalysts include expansion into new geographic markets and product innovation within the nutraceutical and cosmetics sectors. Key value drivers will be improving gross margins, currently at 20.0%, and achieving operational efficiencies. The high beta of 2.28 suggests significant volatility relative to the broader market. Investors should carefully consider the risks associated with investing in a company with current financial performance challenges in a dynamic and competitive industry.
Based on FMP financials and quantitative analysis
ELLXF Key Highlights
- Market Cap of $1.61M indicates a micro-cap company with high growth potential but also higher risk.
- P/E Ratio of -0.41 reflects the company's current lack of profitability.
- Profit Margin of -35.4% highlights the need for improved cost management and revenue generation.
- Gross Margin of 20.0% suggests opportunities for improvement through supply chain optimization and pricing strategies.
- Beta of 2.28 indicates higher volatility compared to the market, reflecting the speculative nature of the stock.
Who Are ELLXF's Competitors?
ELLXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ELLXF's Key Strengths?
- Established brands (Elixinol, Hemp Foods Australia).
- Global distribution network.
- Diverse product range (nutraceuticals, cosmetics, food).
- Focus on hemp-derived products.
What Are ELLXF's Weaknesses?
- Negative profitability.
- High operating expenses.
- Limited market share.
- Dependence on regulatory environment.
What Could Drive ELLXF Stock Higher?
- Potential regulatory changes in key markets could create new opportunities for hemp-derived products.
- Expansion into new geographic markets, particularly in Asia-Pacific and South America.
- Product innovation and diversification efforts to meet evolving consumer demands.
What Are the Key Risks for ELLXF?
- Financial-distress signal — its Altman Z-Score of -20.61 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-76.3%) — the business is not currently generating profit on shareholder capital.
- Intense competition from established players and new entrants in the hemp-derived products market.
- Evolving regulatory landscape and potential for stricter regulations on hemp-derived products.
- Changing consumer preferences and potential for decreased demand for hemp-derived products.
- Negative profitability and high operating expenses pose challenges to financial sustainability.
What Are the Growth Opportunities for ELLXF?
- Expansion into New Geographic Markets: Elixinol can pursue growth by expanding its presence in untapped geographic markets, particularly in Asia-Pacific and South America. These regions present significant opportunities due to increasing consumer interest in natural health products. Successful market entry requires adapting product offerings to local preferences and navigating regulatory frameworks. This expansion could increase revenue by an estimated 20% within the next three years, contingent on effective market penetration strategies.
- Product Innovation and Diversification: Elixinol can drive growth through continuous product innovation, introducing new hemp-derived products targeting specific health and wellness needs. This includes developing specialized formulations for sleep, anxiety, and pain management, capitalizing on the growing demand for targeted health solutions. Successful product innovation can enhance brand loyalty and attract new customer segments, potentially increasing revenue by 15% annually.
- Strategic Partnerships and Collaborations: Elixinol can leverage strategic partnerships with established retailers and distributors to expand its market reach and distribution network. Collaborations with health and wellness influencers can also enhance brand awareness and credibility. These partnerships can provide access to new customer bases and distribution channels, contributing to a 10% increase in revenue within the next two years.
- Focus on E-commerce and Direct-to-Consumer Sales: Elixinol can strengthen its online presence and direct-to-consumer sales channels to improve profitability and customer engagement. Investing in e-commerce platforms and digital marketing strategies can enhance brand visibility and drive online sales. This approach allows for direct customer interaction and personalized marketing, potentially increasing revenue by 25% over the next three years.
- Regulatory Compliance and Advocacy: Elixinol can invest in ensuring full compliance with evolving regulatory requirements in key markets. Proactive engagement with regulatory bodies and industry advocacy can help shape favorable regulatory outcomes. This includes advocating for clear and consistent regulations for hemp-derived products, reducing regulatory uncertainty and fostering a more stable business environment. Compliance and advocacy efforts can enhance the company's reputation and market access, contributing to long-term growth.
What Opportunities Does ELLXF Have?
- Expansion into new geographic markets.
- Product innovation and diversification.
- Strategic partnerships and collaborations.
- Growth in the hemp-derived products market.
What Threats Does ELLXF Face?
- Intense competition.
- Evolving regulatory landscape.
- Changing consumer preferences.
- Economic downturns.
What Are ELLXF's Competitive Advantages?
- Brand recognition through Elixinol and Hemp Foods Australia brands.
- Established distribution network in the Americas, Europe, and Australia.
- Proprietary formulations for hemp-derived products.
- Focus on quality and compliance in manufacturing processes.
What Does ELLXF Do?
Elixinol Wellness Limited was incorporated in 2017 and is headquartered in Sydney, Australia. The company manufactures and distributes hemp-derived nutraceuticals, cosmetics, and food products. It operates through its subsidiaries under the Elixinol and Hemp Foods Australia brands, targeting markets in the Americas, Europe, and Australia. Its product range includes hemp-derived cannabidiol (CBD) products, dietary supplements, topicals, and skincare products. The company's evolution involved a name change from Elixinol Global Limited to Elixinol Wellness Limited in May 2021, reflecting a strategic shift towards wellness-focused products. Elixinol aims to capitalize on the increasing consumer interest in hemp-based health and wellness solutions. The company's products are designed to meet diverse consumer needs, ranging from dietary supplements to skincare, all leveraging the perceived benefits of hemp and CBD. Elixinol Wellness Limited seeks to establish itself as a prominent player in the global hemp-derived products market.
What Products and Services Does ELLXF Offer?
- Manufactures hemp-derived nutraceuticals.
- Distributes hemp-derived cosmetics.
- Produces hemp-derived food products.
- Offers hemp-derived cannabidiol (CBD) products.
- Provides dietary supplements.
- Sells topical products.
- Markets skincare products under the Elixinol brand.
- Markets hemp food products under the Hemp Foods Australia brand.
How Does ELLXF Make Money?
- Manufactures hemp-derived products through its subsidiaries.
- Distributes products through retail channels and online platforms.
- Generates revenue through the sale of nutraceuticals, cosmetics, and food products.
- Focuses on the Elixinol and Hemp Foods Australia brands.
What Industry Does ELLXF Operate In?
Elixinol Wellness Limited operates in the specialty and generic drug manufacturing industry, specifically focusing on hemp-derived products. The market for CBD and hemp-based products has seen substantial growth, driven by increasing consumer awareness of potential health benefits. However, the industry is also characterized by intense competition and evolving regulatory landscapes. Elixinol competes with other companies in the nutraceutical, cosmetics, and food sectors, requiring a strong brand presence and effective distribution strategies to capture market share. The industry is subject to changing consumer preferences and regulatory requirements, impacting business strategies.
Who Are ELLXF's Key Customers?
- Consumers seeking hemp-derived nutraceuticals.
- Individuals interested in hemp-based cosmetics.
- Customers looking for hemp-derived food products.
- Health and wellness enthusiasts.
ROE -76%Key Financial Metrics
Return on equity for Elixinol Wellness Limited stands at -76.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -34.5%, showing how much profit it generates from its asset base. A current ratio of 0.86 means current liabilities exceed short-term assets, a liquidity point worth watching.
Elixinol Wellness Limited (ELLXF) Valuation Context
Valued at $1.61M, ELLXF is classified as a micro-cap stock.
Company Profile
Elixinol Wellness Limited operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Sydney, AU. The company is led by CEO Natalie Butler. ELLXF has traded publicly since 2018.
F-Score 5/9Financial Health
Elixinol Wellness Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -20.61 places it in the distress zone, a signal of elevated financial risk.
ELLXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Elixinol's future, indicating that executives believe in the company's potential growth.
- Community sentiment has shifted positively, with discussions highlighting the company's commitment to product quality and innovation.
- The wellness industry is experiencing a surge, and Elixinol is well-positioned to capitalize on this trend with its diverse product offerings.
- Recent partnerships and collaborations have enhanced market visibility, attracting more attention from potential investors.
Bear Case
- Some analysts express concerns over the company's profitability, citing ongoing challenges in achieving sustainable revenue growth.
- Social sentiment shows skepticism regarding the competitive landscape, with many players vying for market share in the wellness sector.
- Recent regulatory changes in the cannabis industry have created uncertainty, potentially impacting Elixinol's operational strategies.
- Community discussions reflect worries about the company's ability to adapt to rapidly changing consumer preferences and market demands.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ELLXF Latest News
No recent news available for ELLXF.
ELLXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ELLXF.
Price Targets
Wall Street price target analysis for ELLXF.
ELLXF MoonshotScore
What does this score mean?
The MoonshotScore rates ELLXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Natalie Butler
CEO
Natalie Butler is the CEO of Elixinol Wellness Limited. Her background includes experience in the health and wellness industry, with a focus on strategic leadership and business development. She has a proven track record of driving growth and innovation in competitive markets. Her expertise lies in developing and executing strategic plans to enhance market presence and profitability. She brings a wealth of knowledge in brand management and product development to Elixinol Wellness Limited.
Track Record: Since becoming CEO, Natalie Butler has focused on streamlining operations and expanding Elixinol's product offerings. She has overseen the launch of new product lines and the implementation of cost-saving measures. Her leadership has been instrumental in navigating the evolving regulatory landscape and positioning the company for future growth.
ELLXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Elixinol Wellness Limited may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges such as the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight and reporting requirements.
- Potential for price volatility and manipulation.
- Information asymmetry and limited financial disclosure.
- Higher risk of fraud or mismanagement.
- Verify the company's financial statements and SEC filings.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC investments.
- Established brands (Elixinol, Hemp Foods Australia).
- Global distribution network.
- Focus on quality and compliance in manufacturing processes.
- Experienced management team.
- Active investor relations and communication.
What Investors Ask About Elixinol Wellness Limited (ELLXF) — Healthcare
What does Elixinol Wellness Limited do?
Elixinol Wellness Limited manufactures and distributes hemp-derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands. The company focuses on providing a range of hemp-derived cannabidiol (CBD) products, dietary supplements, topicals, and skincare products to consumers in the Americas, Europe, and Australia. Its business model centers on leveraging the growing demand for hemp-based health and wellness solutions through diverse product offerings and established distribution channels.
What are the main risks for ELLXF?
The main risks for Elixinol Wellness Limited include intense competition in the hemp-derived products market, evolving regulatory landscapes, and changing consumer preferences. The company's negative profitability and high operating expenses pose financial sustainability challenges. Additionally, its OTC Other listing carries inherent risks such as limited liquidity, lack of regulatory oversight, and potential price volatility. Investors should carefully assess these risks before investing in ELLXF.
What are the key factors to evaluate for ELLXF?
Evaluate ELLXF on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does ELLXF data refresh on this page?
ELLXF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ELLXF's recent stock price performance?
Elixinol Wellness Limited (ELLXF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands (Elixinol, Hemp Foods Australia). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ELLXF overvalued or undervalued right now?
Valuing Elixinol Wellness Limited (ELLXF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ELLXF?
Before investing in Elixinol Wellness Limited (ELLXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ELLXF to a portfolio?
Key strength of Elixinol Wellness Limited (ELLXF): Established brands (Elixinol, Hemp Foods Australia). Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information and may be subject to change.
- OTC market investments carry higher risks than exchange-listed stocks.
- Analyst consensus is not available due to limited coverage.